Status: Recruiting
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.
Participants needed: 81
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb GmbHUpdated: Jun 22, 2025Locations: 1
Eligibility criteria
Subjects already scheduled for bilateral refractive laser surgery targeting emme... [+12]
Subjects for whom the combination of their baseline corneal thickness and the pl... [+16]